139 related articles for article (PubMed ID: 23790650)
21. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
Epperla N; Hamadani M
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038
[TBL] [Abstract][Full Text] [Related]
22. Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity.
Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Busque L; Ahmad I; Roy J
Biol Blood Marrow Transplant; 2012 Jun; 18(6):951-7. PubMed ID: 22155507
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.
Ferrara F; Viola A; Copia C; Schiavone EM; Celentano M; Pollio F; D'Amico MR; Palmieri S
Hematol Oncol; 2006 Jun; 24(2):73-7. PubMed ID: 16550628
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.
Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Sperotto A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P
Biol Blood Marrow Transplant; 2012 Apr; 18(4):617-26. PubMed ID: 21820394
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment with third stem cell transplant from an allogeneic donor for a patient with relapsed diffuse large B-cell lymphoma.
Takasaki H; Ishii Y; Yamamoto W; Tsuchihashi H; Motomura S; Tomita N; Ishigatsubo Y; Sakai R
Exp Clin Transplant; 2013 Apr; 11(2):199-202. PubMed ID: 23425447
[TBL] [Abstract][Full Text] [Related]
26. Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
Yoshimi A; Izutsu K; Takahashi M; Kako S; Oshima K; Kanda Y; Motokura T; Chiba S; Momose T; Ohtomo K; Kurokawa M
Am J Hematol; 2008 Jun; 83(6):477-81. PubMed ID: 18266206
[TBL] [Abstract][Full Text] [Related]
27. [Role and progress of allogeneic hematopoietic stem cell transplantation in the treatment of refractory/relapsed diffuse large B-cell lymphoma].
Cao LQ; Mo XD
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):308-312. PubMed ID: 38716606
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.
Izumi K; Kanda J; Nishikori M; Arai Y; Ishikawa T; Yoshioka S; Ueda Y; Maeda T; Yonezawa A; Anzai N; Moriguchi T; Imada K; Akasaka T; Nohgawa M; Itoh M; Aiba A; Tsunemine H; Watanabe M; Kondo T; Takaori-Kondo A
Ann Hematol; 2019 Dec; 98(12):2815-2823. PubMed ID: 31713653
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
Bento L; Gutiérrez A; Novelli S; Montoro J; Piñana JL; López-Corral L; Cabrero M; Martín-Sancho A; Gutiérrez-García G; Ortiz-Moscovich M; Bastos-Oreiro M; Dorado N; Pérez A; Hernani R; Ferrà C; Parody R; García-Cadenas I; Herrera P; Rodríguez G; Rodríguez N; Martín C; Yáñez L; Zanabili J; Varela MR; López-Godino O; Heras I; Español I; Martínez C; Pérez-Simón JA; Solano C; Sureda A; Sierra J; Sampol A; Caballero D;
Bone Marrow Transplant; 2021 Aug; 56(8):1919-1928. PubMed ID: 33767400
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic SCT for peripheral T-cell lymphoma.
Gutiérrez A; Caballero MD; Pérez-Manga G; Rodriguez J
Bone Marrow Transplant; 2008 Dec; 42(12):773-81. PubMed ID: 18936735
[TBL] [Abstract][Full Text] [Related]
32. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
33. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
Oliansky DM; Czuczman M; Fisher RI; Irwin FD; Lazarus HM; Omel J; Vose J; Wolff SN; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2011 Jan; 17(1):20-47.e30. PubMed ID: 20656046
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
Maloney D
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296
[TBL] [Abstract][Full Text] [Related]
35. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
36. [Stem cell transplantation in patients with low-grade non-Hodgkin lymphoma].
Mandigers CM; Schattenberg AV; Raemaekers JM
Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2045-8. PubMed ID: 11072506
[TBL] [Abstract][Full Text] [Related]
37. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
Wannesson L; Zucca E
Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
[No Abstract] [Full Text] [Related]
38. Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
Nagle SJ; Woo K; Schuster SJ; Nasta SD; Stadtmauer E; Mick R; Svoboda J
Am J Hematol; 2013 Oct; 88(10):890-4. PubMed ID: 23813874
[TBL] [Abstract][Full Text] [Related]
39. Conventional allograft and autograft in low grade lymphoma.
Avivi I; Goldstone AH
Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.
Kim JW; Kim BS; Bang SM; Kim I; Kim DH; Kim WS; Yang DH; Lee JJ; Lee JH; Kim JS; Sohn SK; Yhim HY; Kwak JY; Yoon SS; Lee JS; Park S; Kim BK;
Ann Hematol; 2011 Dec; 90(12):1409-18. PubMed ID: 21468694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]